ISSN: 2577-4379
Authors: Kwena AVM*
The Covid-19 pandemic has in recent history been one of the most serious health problems faced by mankind this century. Digital handwashing is one of the latest ways utilized to reduce disease transmission in addition to regular handwashing as prescribed. Attempts to control and manage the pandemic have involved use of various types of vaccines as recommended by WHO [1]. Equitable access to safe and effective vaccines is critical to ending the COVID 19 pandemic. The Oxford University AstraZeneca is one of the many vaccines that have been recommended by WHO for such use. Different reactions to COVID 19 vaccine have been reported in literature and those linked to AstraZeneca vaccine have also been documented. Oxford-AstraZeneca (AZD1222) was developed in the United Kingdom by the British-Swedish multinational pharmaceutical company AstraZeneca Inc in collaboration with the University of Oxford. There are, however, two versions of this vaccine that are being produced by AstraZeneca-SKBio (Republic of South Korea) and the Serum Institute of India. Both versions have been approved by the WHO for emergency use. This vaccine is taken in 2 doses and can be stored at between 2 to 8 degrees Celsius. It has about 63 percent efficacy. According to the World Health Organization, this vaccine may not be suitable for persons who have a history of severe allergic reactions. The WHO recommends a 0.5ml per dose that should be in intervals of between 8 to 12 weeks. Here we give a case report of such a reaction from an individual that had received the recommended two doses of AstraZeneca vaccine.
Keywords:
